Presentation Information

[MSP-03-2]Utility of Neuropsychological Tests in Identifying Amyloid PET Positivity for Lecanemab Eligibility

Naoko Kawabe1, Satoshi Hosoki2, Chiharu Watanabe1, Yurina Nishio1, Kohei Hayase1, Manami Deguchi1, Hiroshi Komatsu1, Yuriko Kawakami1, Kentaro Iwata1, Kota Maekawa2, Nobuo Kohara1,2, Michi Kawamoto2 (1.Department of Rehabilitation, Kobe City Medical Center General Hospital, Japan, 2.Department of Neurology, Kobe City Medical Center General Hospital, Japan)

Password required to view